Advertisement

Complementary and alternative medicine in ADHD treatment: more soundly designed clinical trials needed

  • Rong-Wang YangEmail author
  • Rong Li
Letter to Editor

We read with great interest the article [1] by Dehbokri et al. published in the Journal recently. The authors carried out a double-blind, randomized clinical trials to study the effects of vitamin D supplementation on children with attention deficit hyperactivity disorder (ADHD) for 6 weeks. The results showed that vitamin D could improve ADHD symptoms with a particular effect on inattention symptoms. It is a significant report to examine whether vitamin D supplementation can benefit ADHD symptoms, which draw our attentions on the interesting topic of vitamin and mineral supplementation in the treatment of ADHD.

ADHD is a neuro-developmental disorder defined by DSM-5 [2], which means the functional impairments of ADHD symptoms to individuals would not limited in childhood [3]. Currently, the treatment strategies recommended by most guidelines include psychopharmacological drugs and behavioral modifications that have been proven effective [4, 5, 6]. Behavioral modifications can...

Notes

Acknowledgements

We thank Prof. Zhao, Dr. Gao, Dr. Zhang and Dr. Lin for their assistance in this work.

Author contributions

RY and RL reviewed the literatures, and wrote the draft. Both the authors approved the final version.

Funding

None.

Compliance with ethical standards

Ethical approval

Not needed.

Conflict of interest

No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

References

  1. 1.
    Dehbokri N, Noorazar G, Ghaffari A, Mehdizadeh G, Sarbakhsh P, Ghaffary S. Effect of vitamin D treatment in children with attention-deficit hyperactivity disorder. World J Pediatr. 2018.  https://doi.org/10.1007/s12519-018-0209-8.Google Scholar
  2. 2.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.CrossRefGoogle Scholar
  3. 3.
    Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111:279–89.CrossRefGoogle Scholar
  4. 4.
    Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007–22.CrossRefGoogle Scholar
  5. 5.
    National Collaborating Centre for Mental Health, National Institute for Health and Care Excellence: Clinical Guidelines. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. Leicester: British Psychological Society; 2018.Google Scholar
  6. 6.
    Gorman DA, Gardner DM, Murphy AL, Feldman M, Belanger SA, Steele MM, et al. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. Can J Psychiatry. 2015;60:62–76.CrossRefGoogle Scholar
  7. 7.
    Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can Med Assoc J. 2001;165:1475–88.Google Scholar
  8. 8.
    Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR. Physician perceptions of the use of medications for attention deficit hyperactivity disorder. J Manag Care Pharm. 2003;9:416–23.Google Scholar
  9. 9.
    Purohit MP, Zafonte RD, Sherman LM, Davis RB, Giwerc MY, Shenton ME, Yeh GY. Neuropsychiatric symptoms and expenditure on complementary and alternative medicine. J Clin Psychiatry. 2015;76:e870–6.CrossRefGoogle Scholar
  10. 10.
    Weber W, Newmark S. Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatr Clin N Am. 2007;54:983–1006.CrossRefGoogle Scholar
  11. 11.
    Bussing R, Zima BT, Gary FA, Garvan CW. Use of complementary and alternative medicine for symptoms of attention-deficit hyperactivity disorder. Psychiatr Serv. 2002;53:1096–102.CrossRefGoogle Scholar
  12. 12.
    Snyder J, Brown P. Complementary and alternative medicine in children: an analysis of the recent literature. Curr Opin Pediatr. 2012;24:539–46.CrossRefGoogle Scholar
  13. 13.
    Rapaport MH. Patients’ preference for complementary and alternative medicine presents challenges for research. J Clin Psychiatry. 2015;76:e886–7.CrossRefGoogle Scholar
  14. 14.
    Chan E. The role of complementary and alternative medicine in attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2002;23(1 Suppl):S37–45.CrossRefGoogle Scholar
  15. 15.
    Espin-Jaime JC, Cerezo-Navarro MV. Dietary supplements in child and adolescent psychiatry. Actas Esp Psiquiatr. 2017;45(Supplement):48–64.Google Scholar
  16. 16.
    Arnold LE, Bozzolo H, Hollway J, Cook A, DiSilvestro RA, Bozzolo DR, Crowl L, Ramadan Y, Williams C. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005;15:628–36.CrossRefGoogle Scholar
  17. 17.
    Yang R, Zhang Y, Gao W, Lin N, Li R, Zhao Z. Blood levels of trace elements in children with attention-deficit hyperactivity disorder: results from a case-control study. Biol Trace Elem Res. 2018.  https://doi.org/10.1007/s12011-018-1408-9.Google Scholar
  18. 18.
    Viktorinova A, Ursinyova M, Trebaticka J, Uhnakova I, Durackova Z, Masanova V. Changed plasma levels of zinc and copper to zinc ratio and their possible associations with parent- and teacher-rated symptoms in children with attention-deficit hyperactivity disorder. Biol Trace Elem Res. 2016;169:1–7.CrossRefGoogle Scholar
  19. 19.
    Black LJ, Allen KL, Jacoby P, Trapp GS, Gallagher CM, Byrne SM, Oddy WH. Low dietary intake of magnesium is associated with increased externalising behaviours in adolescents. Public Health Nutr. 2015;18:1824–30.CrossRefGoogle Scholar
  20. 20.
    Huss M, Volp A, Stauss-Grabo M. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems—an observational cohort study. Lipids Health Dis. 2010;9:105.CrossRefGoogle Scholar
  21. 21.
    Bilici M, Yildirim F, Kandil S, Bekaroglu M, Yildirmis S, Deger O, Ulgen M, Yildiran A, Aksu H. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:181–90.CrossRefGoogle Scholar
  22. 22.
    Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry. 2004;4:9.CrossRefGoogle Scholar
  23. 23.
    Zamora J, Velasquez A, Troncoso L, Barra P, Guajardo K, Castillo-Duran C. Zinc in the therapy of the attention-deficit/hyperactivity disorder in children. A preliminar randomized controlled trial. Arch Latinoam Nutr. 2011;61:242–6.Google Scholar
  24. 24.
    Arnold LE, Disilvestro RA, Bozzolo D, Bozzolo H, Crowl L, Fernandez S, et al. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol. 2011;21:1–19.CrossRefGoogle Scholar
  25. 25.
    Salehi B, Mohammadbeigi A, Sheykholeslam H, Moshiri E, Dorreh F. Omega-3 and Zinc supplementation as complementary therapies in children with attention-deficit/hyperactivity disorder. J Res Pharm Pract. 2016;5:22–6.CrossRefGoogle Scholar
  26. 26.
    Arnold LE, DiSilvestro RA. Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005;15:619–27.CrossRefGoogle Scholar
  27. 27.
    Qian Y, Du Q, Qu S, Wang Y. Reliability and validity of the Chinese version of Weiss Functional Impairement Scale-Parent form for school age children. Chin Ment Health J. 2011;25:767–71.Google Scholar
  28. 28.
    Ernst E. Prevalence of complementary/alternative medicine for children: a systematic review. Eur J Pediatr. 1999;158:7–11.CrossRefGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine 2019

Authors and Affiliations

  1. 1.Department of Child Psychology, Children’s HospitalZhejiang University School of MedicineHangzhouChina

Personalised recommendations